Timothy Parry

Director at Claremont Communications.

[England Cricket @englandcricket]

"Like the lion on the cap. 🧢
Be brave, be fearless, be proud." 🦁
Amazing words from @flintoff11 ❤️
Congratulations, @tomhartley100 👏

[Alzheimer's Research UK @AlzResearchUK]

Not all fairytales end the way we expect.

Share now to help us change the ending #ForACure.

https://t.co/EKBE5uf5QU

[Alzheimer's Research UK @AlzResearchUK]

Our hearts go out to Coronation Street star Julie Goodyear and her family, following the announcement that she is living with dementia.

It’s so brave of Julie’s husband to share this news and help raise much-needed awareness of dementia. https://t.co/RadJgmvSEQ

[Alzheimer's Research UK @AlzResearchUK]

We are on the path for a cure, but this is only just the start.

We must keep the momentum going. We will not stop until every person is free from the heartbreak of dementia.

Our Director of Research, @skohlhaas, calls on you to join us. #ForACure 🟧

https://t.co/MV0G2jzDAh

[Alzheimer's Research UK @AlzResearchUK]

Too many of us have felt the devastating reality of dementia. Enough is enough.

As our CEO @HilaryAlzUK says, it's time for change. We are driving the search for a cure, but we need your support.

Stand #ForACure 🟧
https://t.co/tRJDQsgjxA

[🟧 Hilary Evans-Newton 🟧 @HilaryAlzUK]

If nothing changes, 1 in 2 of us will see our lives devastated by dementia - either by developing it ourselves, caring for someone with it, or both. We must act now.
That’s why I’m proud to lead @AlzResearchUK, we exist #ForACure and we will not stop until we find one. Join us.

[Alzheimer's Research UK @AlzResearchUK]

Alzheimer's Research UK stands for everyone affected by dementia.

For too long dementia has taken our memories, our connections, our stories. It has no right to take any of this from us.

We stand #ForACure. 🟧

Will you join us?
https://t.co/EKBE5uf5QU

[Alzheimer's Research UK @AlzResearchUK]

If nothing changes, 1 in 2 of us will see our lives devastated by dementia. Either by caring for someone with the condition, developing it ourselves, or both.

This is why we exist. We're leading the search #ForACure 🟧

Find out more here: https://t.co/rVxVvA0WMV

[Alzheimer's Research UK @AlzResearchUK]

Incredibly encouraging, and another hugely significant moment for dementia research.

A second drug for Alzheimer’s – donanemab - has been shown to slow people’s cognitive decline in a rigorous phase 3 trial.

Coverage here👇
https://t.co/L7qAFv4Kze

[Alzheimer's Research UK @AlzResearchUK]

🚨BREAKING NEWS🚨

The @US_FDA has granted Eisai an accelerated licence for #lecanemab in people with a confirmed diagnosis of mild cognitive impairment or early-stage Alzheimer’s in the US.

Head of Policy, @david_rt84, explains more 👇

https://t.co/h5wARDLITb

[Alzheimer's Research UK @AlzResearchUK]

Exciting findings from a trial of a drug called lecanemab represent a major step forward for dementia research & could herald a new era for people with Alzheimer’s disease. (1/2)

[BBC Breakfast @BBCBreakfast]

'This is a historic moment for Alzheimer's research'

Susan Kohlhaas from Alzheimer's Research UK, spoke to #BBCBreakfast about the breakthrough with the drug lecanemab

https://t.co/MhXycSRoQ3

[Timothy Parry @TJParry]

@Panther_Taxis @AlzResearchUK

[Timothy Parry @TJParry]

@ProfRobHoward @AlzResearchUK Good to see you today Rob, on a day of some significance.

[Timothy Parry @TJParry]

There's caveats, and it may be a long road to reaching patients, but the lecanemab announcement feels different. The mechanism of the disease can be got at. I’ve always believed this was possible, but today I know it. Time for a new, lifechanging push for people with dementia.

[Alzheimer's Research UK @AlzResearchUK]

Great news! A new drug, lecanemab, has slowed patients' cognitive decline in a rigorous clinical trial.

It's a modest but clear effect, & next step is to see full data, then make sure it can reach the people who need it most.

More on our website 👉https://t.co/aLRo2SZUE7

[Alzheimer's Research UK @AlzResearchUK]

Great news! A new drug, lecanemab, has slowed patients' cognitive decline in a rigorous clinical trial.

It's a modest but clear effect, & next step is to see full data, then make sure it can reach the people who need it most.

More on our website 👉https://t.co/aLRo2SZUE7

[Timothy Parry @TJParry]

@Jade_Rolph @SelinaWray I ended up in the same position on this one...